TMCnet News
Research and Markets: Anti-Infective Peptides Competitor AnalysisDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/kclc79/competitor) has announced the addition of the "Competitor Analysis: Anti-Infective Peptides" report to their offering. The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective peptides as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export a individual report. Anti-Bacterial Peptides: Anti-bacterial peptides are used to treat infectious diseases such as complicated skin and skin structure infections (cSSSI), gram-positive and gram-negative infections, prevention of catheter-related infections, otitis media, gingivitis and many more. Anti-Fungal Peptides: Anti-fungal peptides are used to treat infections such as oesophageal candidiasis, aspergillosis, oral candida infections, vaginal yeast infections and many more. Anti-Viral Peptides: Anti-viral peptides are used to treat infections such as HIV and AIDS, influenza incl. H5N1 strains, hepatitis C virus infections (HCV). The report includes a compilation of current active projects in research and development of anti-infective peptides. In addition, the report lists company-specific R&D pipelines of anti-infective peptides. Competitor projects are listed in a tabular format providing information on:
Key Topics Covered: 1. 2013 Sales of Major Anti-Infective Peptides 2. Anti-Bacterial Peptides 3. Anti-Fungal Peptides 4. Anti-Viral Peptides 5. Corporate Anti-Infective Peptide R&D Pipelines For more information visit http://www.researchandmarkets.com/research/kclc79/competitor
|
